Today: 7 April 2026
Subscribe
Browse Category

Earnings Reports 22 January 2026 - 23 January 2026

Eli Lilly stock rises after hours as fresh GLP-1 stop data revives a big question ahead of earnings

Eli Lilly stock rises after hours as fresh GLP-1 stop data revives a big question ahead of earnings

Eli Lilly shares rose 0.8% after hours Thursday to $1,087.38. A Reuters report cited nference data showing 36% of patients who stopped Lilly’s weight-loss drug tirzepatide kept weight off after six months, while 28% regained weight. Lilly director Juan R. Luciano acquired 15.286 shares via a deferral plan, per SEC filing. The company reports Q4 earnings February 4.
23 January 2026
···
Lam Research stock slips 3% after fresh high as Citi, Deutsche Bank lift targets into earnings

Lam Research stock slips 3% after fresh high as Citi, Deutsche Bank lift targets into earnings

Lam Research shares fell 3.4% to $220.70 Thursday, slipping from a 52-week high reached the previous day. The decline came despite Citi and Deutsche Bank raising their price targets ahead of Lam’s Jan. 28 earnings. Investors are watching for 2026 chip-equipment spending forecasts, not just quarterly results. Lam’s trading volume was near average as the S&P 500 rose 0.6%.
23 January 2026
··
Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson stock price today: JNJ ends higher, but talc case stays in focus after earnings

Johnson & Johnson closed up 0.3% at $218.49 Thursday after reporting Q4 revenue of $24.56 billion and adjusted earnings of $2.46 per share. The company projected 2026 sales above estimates but faces ongoing pressure from U.S. drug pricing, tariffs, and talc litigation. A court-appointed special master recommended allowing expert testimony in the New Jersey talc case. J&J plans to appeal.
22 January 2026
···
Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

UnitedHealth shares rose 1.96% to $354.47 Thursday as investors focused on the insurer’s plan to rebate ACA profits starting in 2026. CEO Stephen Hemsley faced lawmakers over rising insurance costs, while analysts await the company’s Jan. 27 results and 2026 outlook. ACA premiums are projected to more than double next year, with enrollment expected to fall by two-thirds.
22 January 2026
··
Microsoft stock drops after Redburn cuts target as Jan. 28 earnings loom

Microsoft stock drops after Redburn cuts target as Jan. 28 earnings loom

Microsoft shares fell 2.3% Wednesday after Rothschild & Co Redburn cut its price target to $450, citing a neutral outlook. The stock touched $438.68 before closing at $444.11, with trading volume up 45%. The move comes days ahead of Microsoft’s Q2 earnings on Jan. 28, as investors focus on Azure growth and AI spending. Wall Street expects EPS of $3.92 on $80.28 billion in revenue.
22 January 2026
··
P&G stock price jumps after earnings, but a U.S. demand wobble steals the spotlight

P&G stock price jumps after earnings, but a U.S. demand wobble steals the spotlight

Procter & Gamble shares rose 2.7% to $149.93 in after-hours trading Thursday after reporting fiscal Q2 net sales of $22.2 billion, up 1%, and core EPS of $1.88, beating forecasts. Revenue missed estimates, but the company maintained its full-year outlook. Volumes fell 1% as pricing rose 1%. P&G returned $4.8 billion to shareholders through dividends and buybacks.
22 January 2026
··
Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical reported Q4 revenue up 19% to $2.87 billion and adjusted earnings of $2.53 per share, beating analyst estimates. Shares rose about 3% in after-hours trading. The company forecast 13% to 15% growth in da Vinci procedures for 2026, slower than 2025, and warned tariffs may pressure margins. Intuitive installed 532 da Vinci systems in the quarter, ending 2025 with 11,106 in use.
22 January 2026
··
Walmart stock slips after PhonePe IPO stake-sale plan; investors brace for CEO handover and earnings

Walmart stock slips after PhonePe IPO stake-sale plan; investors brace for CEO handover and earnings

Walmart shares fell 1.3% to $117.83 in after-hours trading after filing to cut its PhonePe stake by about 12%. The retailer faces a $10.5 million jury verdict in Maryland over a negligent gun sale. PhonePe’s IPO will not raise new capital, with proceeds going to existing shareholders. Wall Street ended higher Thursday, while Walmart declined.
22 January 2026
··
Capital One’s $5.15B Brex buy hits as COF Q4 earnings miss sends shares lower after hours

Capital One’s $5.15B Brex buy hits as COF Q4 earnings miss sends shares lower after hours

Capital One will acquire fintech Brex for $5.15 billion in cash and stock, according to an SEC filing Thursday. The bank’s adjusted fourth-quarter profit missed estimates, sending shares down 4.2% after hours. Capital One reported a $2.13 billion profit and a $1.4 billion jump in credit loss provisions. The Brex deal is expected to close mid-2026, pending regulatory approval.
22 January 2026
···
GE Aerospace stock price drops 7% after earnings even as 2026 profit forecast tops estimates

GE Aerospace stock price drops 7% after earnings even as 2026 profit forecast tops estimates

GE Aerospace shares fell 7.4% to $295 in after-hours trading Thursday after the company posted its 2026 outlook and quarterly results. Adjusted fourth-quarter revenue rose 20% to $11.87 billion, with EPS at $1.57. GE expects slower growth after 2025, forecasting 2026 adjusted EPS of $7.10–$7.40 and free cash flow of $8.0–$8.4 billion. Investors are watching service pricing and repair delays as airlines flag rising maintenance costs.
22 January 2026
···
Abbott stock sinks 10% after outlook misses estimates — what ABT investors watch next

Abbott stock sinks 10% after outlook misses estimates — what ABT investors watch next

Abbott shares fell about 10% to $108.61 in after-hours trading Thursday after fourth-quarter revenue missed estimates and the company issued a weaker first-quarter profit forecast. Nutrition sales dropped 8.9% to $1.94 billion, and diagnostics revenue declined 2.5%. CEO Robert Ford said nutrition growth will remain “challenged” for several quarters. Abbott expects full-year adjusted earnings of $5.55 to $5.80 per share.
22 January 2026
··
Apple stock edges up, but India antitrust fight and Jan. 29 earnings loom for AAPL

Apple stock edges up, but India antitrust fight and Jan. 29 earnings loom for AAPL

Apple has asked the Delhi High Court to block India’s antitrust regulator from demanding its global financial records, with a hearing set for Jan. 27. Shares closed up 0.28% at $248.35 but slipped 0.03% after hours. Apple warned possible fines could reach $38 billion if global turnover is used. Investors await Apple’s Jan. 29 earnings for updates on iPhone demand and regulatory risks.
22 January 2026
····
Amazon stock price lifts as AMZN sets Feb. 5 earnings call and tariff jitters ease

Amazon stock price lifts as AMZN sets Feb. 5 earnings call and tariff jitters ease

Amazon shares rose 1.3% to $234.34 in after-hours trading Thursday after the company set its fourth-quarter 2025 earnings call for Feb. 5. Traders are watching for tariff developments and the Federal Reserve meeting next week. CEO Andy Jassy said tariffs are starting to affect some Amazon prices. U.S. consumer spending rose 0.5% in November, while the PCE price index climbed 2.8% year-over-year.
22 January 2026
···
Intel stock price whipsaws after earnings as weak outlook collides with supply squeeze

Intel stock price whipsaws after earnings as weak outlook collides with supply squeeze

Intel shares rose 0.2% to $54.32 in after-hours trading Thursday after swinging sharply on its earnings report. The company warned first-quarter revenue would miss Wall Street estimates, citing supply constraints, despite beating forecasts for the December quarter. Fourth-quarter revenue fell 4% to $13.7 billion. Traders focused on updates about Intel’s 18A manufacturing ramp and foundry demand.
22 January 2026
··
Meta stock jumps nearly 6% as AI lab update and Threads ads put earnings in focus

Meta stock jumps nearly 6% as AI lab update and Threads ads put earnings in focus

Meta Platforms shares jumped 5.7% to close near $647.71 Thursday after U.S. stocks rallied on eased tariff threats and strong economic data. The company will expand ads on Threads globally next week and unveiled new internal AI models, according to CTO Andrew Bosworth. Investors await Meta’s earnings next week, focusing on AI spending and ad growth. The FTC will appeal the dismissal of its antitrust case against Meta.
22 January 2026
····
Enphase Energy stock jumps 13% as Goldman turns bullish, with ENPH traders eyeing Feb. 3 earnings

Enphase Energy stock jumps 13% as Goldman turns bullish, with ENPH traders eyeing Feb. 3 earnings

Enphase Energy shares jumped 12.6% to $40.51 Thursday after Goldman Sachs upgraded the stock to Buy and raised its price target to $45. Trading volume topped 11 million shares, and options activity surged 29% above average. SolarEdge and Sunrun also advanced. Enphase will report earnings and hold a conference call on Feb. 3.
22 January 2026
······
1 … 90 91 92 93 94 … 229

Stock Market Today

  • S&P 500 and Nasdaq Edge Higher Amid Iran Deadline Tensions and Oil Price Surge
    April 7, 2026, 5:00 PM EDT. U.S. stock indexes S&P 500 and Nasdaq closed slightly up on Tuesday as oil prices jumped following President Trump's ultimatum on Iran. Brent crude futures rose 1.3% above $111 a barrel, while West Texas Intermediate climbed 3.3% nearing $116. Trump set an 8 p.m. ET deadline for Iran to negotiate or face U.S. airstrikes targeting infrastructure. Overnight reports indicate attacks on Saudi Arabia's petrochemical plants and retaliatory strikes on Iranian infrastructure by U.S. and Israeli forces. Iran has rejected ceasefire proposals, demanding full conflict resolution and reparations. The standoff fuels market caution amid rising geopolitical risks and energy supply concerns.
Go toTop